Tritonpoint Wealth, LLC Castle Biosciences Inc Transaction History
Tritonpoint Wealth, LLC
- $1.08 Trillion
- Q2 2025
A detailed history of Tritonpoint Wealth, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Tritonpoint Wealth, LLC holds 40,777 shares of CSTL stock, worth $665,888. This represents 0.08% of its overall portfolio holdings.
Number of Shares
40,777
Previous 41,637
2.07%
Holding current value
$665,888
Previous $834 Million
0.11%
% of portfolio
0.08%
Previous 0.08%
Shares
7 transactions
Others Institutions Holding CSTL
# of Institutions
192Shares Held
26.6MCall Options Held
9.5KPut Options Held
5K-
Black Rock Inc. New York, NY3.04MShares$49.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$33.4 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.47MShares$24 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.27MShares$20.7 Million2.07% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.2MShares$19.6 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $429M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...